Pharmacologic interception of heme: A potential therapeutic strategy for the treatment of β thalassemia?

Redox Report

Volumn 3, Issue 3, 1997, Pages 159-167

  Scott, M D ^a   Yang, L ^b   Ulrich, P ^b   Shupe, T ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b PICOWER INST FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; CQ D2; GLUTATHIONE; HEME; HEMIN; HEMOGLOBIN; HYDROGEN PEROXIDE; IRON; UNCLASSIFIED DRUG;

ARTICLE; BETA THALASSEMIA; HEMOGLOBINOPATHY; HUMAN; HUMAN CELL; IRON TRANSPORT; LIPID PEROXIDATION; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0030870473     PISSN: 13510002     EISSN: None     Source Type: Journal    
DOI: 10.1080/13510002.1997.11747104     Document Type: Article

References (44)

1. Watkins J A, Kawanishi S, Caughey W S. Autoxidation reactions of hemoglobin A free from other red cell components: A minimal mechanism. Biochem Biophys Res Commun 1985; 132: 742-748.
2. Hebbel R P, Morgan W T, Eaton J W, Hedlund B E. Accelerated autoxidation and heme loss due to instability of sickle hemoglobin. Proc Natl Acad Sci USA 1988; 85: 237-241.
3. Rank B H, Carlsson J, Hebbel R P. Abnormal redox status of membrane-protein thiols in sickle erythrocytes. J Clin Invest 1985; 75: 1531-1537.
4. Scott MD, van den Berg JJM, Repka T et al. Effect of excess α-hemoglobin chains on cellular and membrane oxidation in model β thalassemic cells. J Clin Invest 1993; 91: 1706-1712.
5. Sadrzadeh S M H, Graf E, Panter S S, Hallaway P E, Eaton J W. Hemoglobin: A biologic Fenton reagent. J Biol Chem 1984; 259: 14354-14356.
6. Kuross S A, Hebbel R P. Nonheme iron in sickle erythrocyte membranes: Association with phospholipids and potential role in lipid peroxidation. Blood 1988; 72: 1278-1285.
7. Joshi W, Leb L, Piotrowski J, Fortier N, Snyder L M. Increased sensitivity of isolated alpha subunits of normal human hemoglobin to oxidative damage and crosslinkage with spectrin J Lab Clin Med 1983; 102: 46-52
8. Scott M D, van den Berg J, Wagner T C, Rouyer-Fessard Ph, Beuzard Y, Lubin B H. Effect of entrapped α-hemoglobin chains on erythrocyte oxidation. Blood 1990; 76 (suppl.1) 290 (75a).
9. Scott M D, Eaton J W Thalassemic crythrocytes: Cellular suicide arising from iron and glutathione-dependent oxidation reactions? Br J Haem 1995; 91: 811-819.
10. Fosburg M T, Nathan D G. Treatment of Cooley's anemia. Blood 1990; 76: 435-444.
11. Banyal H S, Fitch C D. Ferriprotoporphyrin IX binding substances and the mode of action of chloroquine against malaria. Life Sci 1982; 31: 1141-1144.
12. Fitch C D. Ferriprotoporphyrin IX: role in chloroquine susceptibility and resistance in malaria. Prog Clin Biol Res 1989; 313: 45-52
13. Fitch C D, Chevli R, Kanjananggulpan P, Dutta P, Chevli K, Chou A C. Intracellular ferriprotoporphyrin IX is a lytic agent. Blood 1983; 62: 1165-1168.
14. Meshnick S R. Chloroquine as intercalator: a hypothesis revived Parasitol Today 1990; 6: 77-79
15. Wood P A, Rock L M, Eaton J W. Chloroquine resistance and host cell hemoglobin catabolism in Plasmodium berghei Prog Clin Biol Res 1984; 155: 159-169.
16. Zhang Y, Hempelmann E. Lysis of malarial parasites and erythrocytes by ferriprotoporphyrin IX-chloroquine and the inhibition of this effect by proteins. Biochem Pharmacol 1987, 36: 1267-1273.
17. Elder G H The cutaneous porphyrias. Semin Dermatol 1990; 9: 63-69.
18. Goerz G, Bolsen K, Merk H. Influence of chloroquine on the porphyrin metabolism. Arch Dermatol Res 1985; 277: 114-117.
19. Sweeney G D. Porphyria cutanea tarda, or the uroporphyrinogen decarboxylase deficiency diseases. Clin Biochem 1986; 19: 3-15.
20. Chou A C, Fitch C D. Hemolysis of mouse erythrocytes by ferriprotoporphyrin IX and Chloroquine: Chemotherapeutic implications. J Clin Invest 1980; 166: 856-858
21. Dutta P, Fitch C D. Diverse membrane-active agents modify the hemolytic response to ferriprotoporphyrin IX. J Pharm Exp Therapeutics 1983; 225: 729-734.
22. Abraham E C, Reese A, Stallings M, Huisman T H J Separation of human hemoglobins by DEAE-cellulose chromatography using glycine-KCN-NaCl developers. Hemoglobin 1976; 1: 27-14.
23. Robinson A R, Robson M, Harrison A P, Zuelzer W W. A new technique for differentiation of hemoglobin. J Lab Clin Med 1957; 50: 745-752.
24. Bucci E, Fronticelli C. A new method for the preparation of α and β subunits of human hemoglobin. J Biol Chem 1965; 240: 551-552.
25. Spence J T, Underwood B J, Duncan C P, Cotton J W. Elementary Statistics, 3E. New York, Appleton-Century-Crofts 1968: 108-112.
26. Dodge J T, Mitchell C, Hanahan D J. The preparation and characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys 1963; 100: 119-130.
27. Artiss J D, Vinogradov S, Zak B. Spectrophotometric study of several sensitive reagents for serum iron. Clin Biochem 1981; 14: 311-315.
28. Chung M C. A specific iron stain for iron-binding proteins in polyacrylamide gels: application to transferrin and lactoferrin. Anal Biochem 1985; 48: 498-502.
29. Gutteridge J M C, Free radical damage to lipids, amino acids, carbohydrates, and nucleic acids determined by thiobarbituric acid reactivity. Int J Biochem 1982; 14: 649-653.
30. Jacob H S, Jandl J H. A simple visual screening test for glucose-6-phosphate dehydrogenase deficiency employing ascorbate and cyanide. N Engl J Med 1966, 274. 1162-1167
31. Margoliash E, Novogrodsky A, Schejter A. Irreversible reaction of 3-amino-1,2,4- triazole and related inhibitors with the protein of catalase. Biochem J 1960; 74 339-348
32. Winterbourn C C. Oxidative reactions of hemoglobin. Meth Enzymol 1990; 186: 265-272.
33. Szebeni J, Winterbourn C C, Carrell R W. Oxidative interactions between hemoglobin and membrane lipid. A liposome model. Biochem J 1984; 220: 685-692.
34. Scott M D, Kuypers F A, Bütikofer P, Bookchin R M, Ortiz O, Lubin B H. Effect of osmotic lysis-resealing on red cell structure and function. J Lab Clin Med 1990; 115: 470-480.
35. Scott M D, Rouyer-Fessard P, Lubin B H, Beuzard Y. Entrapment of purified α- hemoglobin chains in normal erythrocytes: A model for δ thalassemia. J Biol Chem 1990; 265: 17953-17959.
36. Scott M D, Rouyer-Fessard P, Ba M S, Lubin B H, Beuzard Y. α- and β- hemoglobin chain induced changes in normal erythrocyte deformability: comparison to β thalassemia intermedia and Hb H disease. Br J Haem 1992; 80: 519-526.
37. Scott M D. Entrapment of purified α-hemoglobin chains in normal erythrocytes as a model of human β thalassemia. In: Magnani M, DeLoach J R eds. The Use of Resealed Erythrocytes as Carriers and Bioreactors. New York: 1982; Plenum, 139-148.
38. Scott M D, Ranz A, Kuypers F A, Lubin B H, Meshnick S R. Parasite uptake of desferrioxamine: a prerequisite for antimalarial activity. Br J Haem 1990; 75: 598-602.
39. Scott M D, Wagner T C. Chloroquine inhibition of iron release from hemin, hemoglobin and a-hemoglobin chains. Blood 1992;80(suppl. 1), 290.
40. Brown S B, Hatzikonstantinou H. The dimerization of ferrihaems: IV. Studies on haematoferrihaem and a general appraisal of the nature and implications of dimerization. Biochim Biophys Acta 1979; 585: 141-153.
41. Brown S B, Hatzikonstantinou H, Herries D G. The dimerization of ferrihaems: I. The effect of buffer ions and specific cations on deuteroferrihaem dimerization. Biochim Biophys Acta 1978; 539: 338-351.
42. Brown S B, Hatzikonstantinou H. The dimerization of ferrihaems: II. Equilibrium and kinetic studies of mesoferrihaem dimerization. Biochim Biophys Acta 539: 352-363.
43. Slater A F, Swiggard W J. Orton B R, Flitter W D, Goldberg D E, Cerami A, Henderson G B. An iron-carboxylate bond links the heme units of malaria pigment. Proc Natl Acad Sci USA 1991; 88: 325-329.
44. Slater A F, Cerami A. Inhibition by chloroquine of a novel heme polymerase enzyme activity in malaria trophozoites. Nature 1992; 355: 167-169